HealthEquity(HQY),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

HQY HealthEquity

Market Closed 09-18 16:00:00 EDT

95.14

+0.63

+0.67%

盘后95.14

+0.00+0.00%

19:30 EDT

High95.58	Low93.47	Vol1.30M
Open94.87	D1 Closing94.51	Amplitude2.23%
Mkt Cap7.87B	Tradable Cap7.67B	Total Shares82.72M
T/O123.39M	T/O Rate1.61%	Tradable Shares80.61M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"HQY","market":"US","secType":"STK","nameCN":"HealthEquity","latestPrice":95.14,"timestamp":1789761600000,"preClose":94.51,"halted":0,"volume":1297938,"hourTrading":{"tag":"盘后","latestPrice":95.1425,"preClose":95.14,"latestTime":"19:30 EDT","volume":141508,"amount":13463084.705,"timestamp":1789774206447,"change":0.0025,"changeRate":0.000026,"amplitude":0.000053},"delay":0,"changeRate":0.006665961273939217,"floatShares":80612098,"shares":82715296,"eps":2.763489,"marketStatus":"Market Closed","change":0.63,"latestTime":"09-18 16:00:00 EDT","open":94.87,"high":95.575,"low":93.47,"amount":123391435.26864,"amplitude":0.022273,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":2.763489,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789977600000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1406779200000,"exchange":"NASDAQ","adjPreClose":94.51,"preHourTrading":{"tag":"盘前","latestPrice":94.87,"preClose":94.51,"latestTime":"09:29 EDT","volume":1043,"amount":98936.848108,"timestamp":1789738199999,"change":0.36,"changeRate":0.003809,"amplitude":0.012909},"postHourTrading":{"tag":"盘后","latestPrice":95.1425,"preClose":95.14,"latestTime":"19:30 EDT","volume":141508,"amount":13463084.705,"timestamp":1789774206447,"change":0.0025,"changeRate":0.000026,"amplitude":0.000053},"volumeRatio":1.5430194886250967,"impliedVol":0.3298,"impliedVolPercentile":0.2032},"requestUrl":"/m/hq/s/HQY/tweets","defaultTab":"tweets","newsList":[{"id":"2668894617","title":"U.S. Research Roundup-Amrize, Carmax, VF Corp","url":"https://stock-news.laohu8.com/highlight/detail?id=2668894617","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668894617?lang=en_us&edition=fundamental","pubTime":"2026-09-18 16:13","pubTimestamp":1789719225,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-Amrize, Carmax, VF CorpSept 18 (Reuters)-Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Amrize, Carmax and VF","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260918:nL4N45A0PB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LUMA","PSCM","HUBS","CTSH","GXPC","AZO","ALL","KMX","BETZ","AA","CHRD","ETSY","NFXS","AMRZ","NVST","OSCR","DXCM","CUE","DT","EINC","CRWD","THG","LEN","NFLX","DKUP","CATX","LDOS","CIEN","VFC","FBRT","FLNC","ELOX","EFSC","PSX","KMI","CAG","ESI","NFLW","EMLP","KALU","CENX","MTSI","ARRY","DKNG","HQY","FTCI","NUE","NPCE","PICK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664869632","title":"Does HealthEquity's (HQY) Upgraded Outlook and Buybacks Reveal a New Capital Allocation Playbook?","url":"https://stock-news.laohu8.com/highlight/detail?id=2664869632","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664869632?lang=en_us&edition=fundamental","pubTime":"2026-09-02 03:26","pubTimestamp":1788290818,"startTime":"0","endTime":"0","summary":"In late August 2026, HealthEquity reported second-quarter revenue of US$350.73 million and net income of US$65.64 million, with both earnings per share metrics increasing versus a year earlier.\nAlongside completing a US$351.66 million share repurchase program and filing an employee stock offering shelf, the company raised full-year revenue and earnings guidance, underlining management’s confidence in its operating model.\nWe’ll now examine how HealthEquity’s raised full-year earnings outlook...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6034000-choice1-main-header/1585187559063","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6034000-choice1-main-header/1585187559063"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-hqy/healthequity/news/does-healthequitys-hqy-upgraded-outlook-and-buybacks-reveal","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-hqy/healthequity/news/does-healthequitys-hqy-upgraded-outlook-and-buybacks-reveal","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["HQY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663003155","title":"HealthEquity price target raised to $142 from $135 at Deutsche Bank","url":"https://stock-news.laohu8.com/highlight/detail?id=2663003155","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663003155?lang=en_us&edition=fundamental","pubTime":"2026-08-31 20:36","pubTimestamp":1788179764,"startTime":"0","endTime":"0","summary":"Deutsche Bank raised the firm’s price target on HealthEquity (HQY) to $142 from $135 and keeps a Buy rating on the shares. The firm updated the com...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/healthequity-price-target-raised-to-142-from-135-at-deutsche-bank-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/healthequity-price-target-raised-to-142-from-135-at-deutsche-bank-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DB","HQY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663805070","title":"Deutsche Bank Adjusts HealthEquity Price Target to $142 From $135, Maintains Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2663805070","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663805070?lang=en_us&edition=fundamental","pubTime":"2026-08-31 19:28","pubTimestamp":1788175694,"startTime":"0","endTime":"0","summary":"HealthEquity (HQY) has an average rating of Buy and mean price target of $114.63, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["HQY","DB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663020059","title":"U.S. Research Roundup-Adobe, Braveheart Bio, CACI International","url":"https://stock-news.laohu8.com/highlight/detail?id=2663020059","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663020059?lang=en_us&edition=fundamental","pubTime":"2026-08-31 15:24","pubTimestamp":1788161046,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-Adobe, Braveheart Bio, CACI InternationalAug 31 (Reuters)-Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Adob","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nL4N44S0J8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RDW","RVMD","AIRJ","ATI","ATTO","EIX","FIVN","LUNR","PATH","HONA","BRCC","TPZ","ASST","OHI","PYPL","DLTR","RKLB","BCDF","MADE","PCG","SRE","ADBE","PTGX","SCTX","IBM","KALU","RBRK","DE","ETR","AFRU","FTAG","ANF","ICE","BPOP","HWAY","BURL","SBRA","AFRM","BILT","CRM","BAC","HQY","XTL","ADSK","BRVE","CIEN","MDB","TROW","CACI","BW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662092847","title":"HealthEquity Catalysts Intact After Q2 Beat, RBC Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2662092847","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662092847?lang=en_us&edition=fundamental","pubTime":"2026-08-28 23:40","pubTimestamp":1787931600,"startTime":"0","endTime":"0","summary":"HealthEquity  delivered better-than-expected Q2 results, keeping its margin runway and fiscal 2028 catalysts intact, RBC Capital Markets said in a Thursday note.The report pointed to a record 48% adjusted EBITDA margin, driven by continued AI-enabled service cost reductions.The note said a slower HSA cash-balance growth reflects a deliberate strategy toward higher-value investment accounts andMarketplace engagement. It said the strategy is \"accretive\" rather than a degradation of the model.\"Marketplace and Bronze plan enrollment represent emerging catalysts,\" the report said. The firm's primary offerings are based on the administration of health savings accounts and other consumer-directed benefits.RBC kept its outperform rating and a price target of $108.Price: 96.20, Change: +2.81, Percent Change: +3.01","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2210149790.SGD","LU2095319765.USD","BK4154","LU1169590202.USD","LU2210150020.SGD","LU1169589451.USD","HQY","LU2065731478.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662109639","title":"Analysts Offer Insights on Healthcare Companies: Healthequity (HQY), Kazia Therapeutics (KZIA) and Cerus (CERS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2662109639","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662109639?lang=en_us&edition=fundamental","pubTime":"2026-08-28 21:30","pubTimestamp":1787923834,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Healthequity (HQY), Kazia Therapeutics (KZIA) and Ce...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-healthequity-hqy-kazia-therapeutics-kzia-and-cerus-cers-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-healthequity-hqy-kazia-therapeutics-kzia-and-cerus-cers-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","LU2095319765.USD","BK4154","BK4139","LU0029874061.USD","HQY","BK4585","LU2065731478.USD","LU1169590202.USD","BK4137","LU2210150020.SGD","HCSG","LU0128526141.USD","LU1169589451.USD","CERS","BK4581","XBI","BK4588","LU2210149790.SGD","KZIA","BK4198","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662806422","title":"HealthEquity Price Target Maintained with a $115.00/Share by BTIG","url":"https://stock-news.laohu8.com/highlight/detail?id=2662806422","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662806422?lang=en_us&edition=fundamental","pubTime":"2026-08-28 18:44","pubTimestamp":1787913840,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/HQY/analyst-ratings","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HQY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662103418","title":"HealthEquity Inc. Earnings Call Signals Profitable Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2662103418","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662103418?lang=en_us&edition=fundamental","pubTime":"2026-08-28 08:13","pubTimestamp":1787875984,"startTime":"0","endTime":"0","summary":"Healthequity Inc (($HQY)) has held its Q2 earnings call. Read on for the main highlights of the call. HealthEquity Inc.’s latest earnings call stru...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/healthequity-inc-earnings-call-signals-profitable-growth?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/healthequity-inc-earnings-call-signals-profitable-growth?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HQY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662035921","title":"HealthEquity Director Adrian T. Dillon Disposes of $798,685 in Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2662035921","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662035921?lang=en_us&edition=fundamental","pubTime":"2026-08-28 05:18","pubTimestamp":1787865528,"startTime":"0","endTime":"0","summary":"HealthEquity director Adrian T. Dillon disposes of $798,685 in common sharesHealthEquity director Adrian T. Dillon sold 7,632 shares on Aug. 25, 2026 at USD 32.5 via option exercise.Disposed of 7,632 ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nNDL5gSG4X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"HealthEquity Director Adrian T. Dillon Disposes of $798,685 in Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1169589451.USD","LU2095319765.USD","LU2065731478.USD","LU2210149790.SGD","BK4154","LU1169590202.USD","LU2210150020.SGD","HQY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662085489","title":"HealthEquity falls -14.1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662085489","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662085489?lang=en_us&edition=fundamental","pubTime":"2026-08-27 22:06","pubTimestamp":1787839596,"startTime":"0","endTime":"0","summary":"HealthEquity (HQY) is down -14.1%, or -$14.68 to $89.74. Published first on TheFly – the ultimate source for real-time, market-moving breaking fina...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/healthequity-falls-14-1-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/healthequity-falls-14-1-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2210150020.SGD","HQY","LU2210149790.SGD","BK4154","LU2065731478.USD","LU1169589451.USD","LU1169590202.USD","LU2095319765.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662088049","title":"HealthEquity, Inc. Reports Results for the Quarter Ended July 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2662088049","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662088049?lang=en_us&edition=fundamental","pubTime":"2026-08-27 21:32","pubTimestamp":1787837535,"startTime":"0","endTime":"0","summary":"HealthEquity, Inc. reports results for the quarter ended July 31 - Earnings SummaryHealthEquity, Inc.HQY.OQreported quarterly adjusted earnings of $1.24 per share for the quarter ended July 31, higher","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nL8N44O1BK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210150020.SGD","LU1169590202.USD","LU2065731478.USD","LU1169589451.USD","LU2095319765.USD","LU2210149790.SGD","BK4154","HQY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662073407","title":"HealthEquity Q2 Adjusted Earnings, Revenue Rise; Fiscal 2027 Topline Outlook Lifted","url":"https://stock-news.laohu8.com/highlight/detail?id=2662073407","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662073407?lang=en_us&edition=fundamental","pubTime":"2026-08-27 20:25","pubTimestamp":1787833539,"startTime":"0","endTime":"0","summary":"HealthEquity  reported fiscal Q2 adjusted earnings Thursday of $1.24 per diluted share, compared with $1.08 a year earlier.Analysts polled by FactSet expected $1.19.Total revenue for the three months ended July 31 was $350.7 million, compared with $325.8 million a year earlier.Analysts surveyed by FactSet expected $349.2 million.The company said it now expects fiscal 2027 revenue of $1.411 billion to $1.421 billion, versus a prior outlook of $1.410 billion to $1.420 billion. Analysts expect $1.42 billion.Fiscal 2027 adjusted net income per diluted share is estimated to be $4.66 to $4.73, unchanged from before. Analysts expect $4.72.Shares of the company were down 5.1% in premarket trading Thursday.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["HQY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662870245","title":"HealthEquity Q2 Revenue Beats on HSA Account Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2662870245","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662870245?lang=en_us&edition=fundamental","pubTime":"2026-08-27 20:12","pubTimestamp":1787832731,"startTime":"0","endTime":"0","summary":"HealthEquity Q2 revenue beats on HSA account growthOverviewU.S. HSA custodian's Q2 revenue rose 8%, slightly beating analyst expectationsAdjusted EPS for Q2 beat analyst expectationsCompany repurchase","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nL1N44O0JX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210150020.SGD","LU2210149790.SGD","LU1169589451.USD","LU2095319765.USD","BK4154","LU2065731478.USD","LU1169590202.USD","HQY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662702126","title":"Healthequity Shares Slip 5.2% Premarket After Quarterly Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2662702126","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662702126?lang=en_us&edition=fundamental","pubTime":"2026-08-27 20:10","pubTimestamp":1787832618,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nL4N44O17Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2065731478.USD","LU2210150020.SGD","LU1169589451.USD","HQY","LU2210149790.SGD","LU1169590202.USD","BK4154","LU2095319765.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662702600","title":"HealthEquity Q2 Adj. EPS $1.24 Beats $1.19 Estimate, Sales $350.732M Beat $349.248M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2662702600","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662702600?lang=en_us&edition=fundamental","pubTime":"2026-08-27 20:07","pubTimestamp":1787832472,"startTime":"0","endTime":"0","summary":"HealthEquity (NASDAQ:HQY) reported quarterly earnings of $1.24 per share which beat the analyst consensus estimate of $1.19 by 4.2 percent. This is a 14.81 percent increase over earnings of $1.08 per share from the same","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/08/61458504/healthequity-q2-adj-eps-1-24-beats-1-19-estimate-sales-350-732m-beat-349-248m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HQY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662026997","title":"HealthEquity FY27 Q2 Net Income Rises 10% to $65.6 Million; Revenue Increases 8% to $350.7 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2662026997","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662026997?lang=en_us&edition=fundamental","pubTime":"2026-08-27 20:05","pubTimestamp":1787832307,"startTime":"0","endTime":"0","summary":"HealthEquity FY27 Q2 net income rises 10% to $65.6 million; revenue increases 8% to $350.7 millionHealthEquity reported fiscal Q2 net income up 10% to USD 65.6 million, lifting net income margin 1 per","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nNDL72f14c:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014021.USD","LU2210150020.SGD","BK4112","LU2065731478.USD","LU1169590202.USD","IE00BQXX3D17.EUR","IE00BN0W2T93.GBP","BK4588","LU2210149790.SGD","IE00BN0W2W23.USD","NDAQ","IE00B3QW5Z07.USD","HQY","IE00BQXX3C00.GBP","IE00BKPKM429.USD","IE00B64PRP62.GBP","IE00BQXX3F31.USD","SG9999014039.USD","LU1169589451.USD","IE00BN0W2V16.EUR","SG9999014005.SGD","BCDF","IE00BGHQF748.EUR","LU0314104364.USD","BK4154","LU2095319765.USD","SG9999014013.SGD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662170252","title":"GUIDANCE: (HQY) HealthEquity Expects Fiscal 2027 Adjusted EPS Range $4.66 to $4.73, vs. FactSet Est of $4.72","url":"https://stock-news.laohu8.com/highlight/detail?id=2662170252","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662170252?lang=en_us&edition=fundamental","pubTime":"2026-08-27 20:03","pubTimestamp":1787832225,"startTime":"0","endTime":"0","summary":"GUIDANCE: (HQY) HealthEquity Expects Fiscal 2027 Adjusted EPS Range $4.66 to $4.73, vs. FactSet Est of $4.72","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["HQY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662025357","title":"Healthequity Q2 Revenue USD 350.732 Million Vs. IBES Estimate USD 349.2 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2662025357","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662025357?lang=en_us&edition=fundamental","pubTime":"2026-08-27 20:01","pubTimestamp":1787832062,"startTime":"0","endTime":"0","summary":"BRIEF-Healthequity Q2 Revenue USD 350.732 Million Vs. IBES Estimate USD 349.2 MillionAug 27  - Healthequity Q2 gross profit USD 257.954 million.Q2 operating expenses USD 159.264 millionQ2 pretax profit USD 87.865 million vs. IBES estimate USD 127.9 millionQ2 net income USD 65.644 million vs. IBES estimate USD 102 millionQ2 adjusted EBITDA USD 167 million vs. IBES estimate USD 160.1 millionQ2 EPS USD 0.78Q2 adjusted EPS USD 1.24 vs. IBES estimate USD 1.19outlook FY revenue USD 1,411-1,421 million vs. IBES estimate USD 1,416 million","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nPLXWH87KW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210150020.SGD","LU2210149790.SGD","LU1169589451.USD","LU2095319765.USD","BK4154","LU2065731478.USD","LU1169590202.USD","HQY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662702835","title":"Healthequity Reports Second Quarter Ended July 31, 2026 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2662702835","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662702835?lang=en_us&edition=fundamental","pubTime":"2026-08-27 20:00","pubTimestamp":1787832003,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nTUA75VHBH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2210150020.SGD","LU2210149790.SGD","LU1169589451.USD","LU2095319765.USD","BK4154","LU2065731478.USD","LU1169590202.USD","HQY"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.healthequity.com","stockEarnings":[{"period":"1week","weight":-0.0116},{"period":"1month","weight":-0.0848},{"period":"3month","weight":0.1165},{"period":"6month","weight":0.1743},{"period":"1year","weight":-0.0047},{"period":"ytd","weight":0.0385}],"compareEarnings":[{"period":"1week","weight":-0.0034},{"period":"1month","weight":-0.0096},{"period":"3month","weight":0.02},{"period":"6month","weight":0.1744},{"period":"1year","weight":0.1501},{"period":"ytd","weight":0.117}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"HealthEquity, Inc. provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts. It also provides mutual fund investment platform; and online-only automated investment advisory services through Advisor, a Web-based tool. In addition, the company offers flexible spending accounts; health reimbursement arrangements; and Consolidated Omnibus Budget Reconciliation Act continuation services, as well as administers pre-tax commuter benefit programs. It serves clients through a direct sales force; benefits brokers and advisors; and a network of health plans, benefits administrators, benefits brokers and consultants, and retirement plan record-keepers. HealthEquity, Inc. was incorporated in 2002 and is headquartered in Draper, Utah.","yearOnYearQuotes":[{"month":1,"riseRate":0.583333,"avgChangeRate":0.038213},{"month":2,"riseRate":0.5,"avgChangeRate":0.035966},{"month":3,"riseRate":0.416667,"avgChangeRate":-0.004957},{"month":4,"riseRate":0.5,"avgChangeRate":0.010279},{"month":5,"riseRate":0.916667,"avgChangeRate":0.05387},{"month":6,"riseRate":0.75,"avgChangeRate":0.054725},{"month":7,"riseRate":0.416667,"avgChangeRate":-0.002246},{"month":8,"riseRate":0.416667,"avgChangeRate":-0.009579},{"month":9,"riseRate":0.692308,"avgChangeRate":0.026039},{"month":10,"riseRate":0.5,"avgChangeRate":0.021915},{"month":11,"riseRate":0.666667,"avgChangeRate":0.078662},{"month":12,"riseRate":0.166667,"avgChangeRate":-0.083153}],"exchange":"NASDAQ","name":"HealthEquity","nameEN":"HealthEquity"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.50.0","shortVersion":"4.50.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"HealthEquity(HQY),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest HealthEquity(HQY) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"HealthEquity,HQY,HealthEquity股票,HealthEquity股票老虎,HealthEquity股票老虎国际,HealthEquity行情,HealthEquity股票行情,HealthEquity股价,HealthEquity股市,HealthEquity股票价格,HealthEquity股票交易,HealthEquity股票购买,HealthEquity股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"HealthEquity(HQY),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest HealthEquity(HQY) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}